📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

The knowns and unknowns of teprotumumab for thyroid eye disease. (2021)

First Author: Bednarczuk T

Attributed to: Plasma-cell depletion therapy for severe Graves' disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-8587(21)00076-0

PubMed Identifier: 33865499

Publication URI: http://europepmc.org/abstract/MED/33865499

Type: Journal Article/Review

Volume: 9

Parent Publication: The lancet. Diabetes & endocrinology

Issue: 6

ISSN: 2213-8587